Drug Delivery and Nanocarrier
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 15
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanotechnology has become a powerful tool for developing new solutions in many scientific fields. In medicine, especially particularly drug delivery, this technology has brought important advances and continues to attract interest from researchers. Nanocarriers, such as lipid nanoparticles, polymeric micelles, dendrimers, and metal–organicmetal-organic frameworks, can effectively deliver drugs or diagnostic agents directly to where they are needed. By modifying the surface of these nanotiny carriers, scientists researchers can improve their compatibility with the body, increase how long they circulate in the bloodstream, and use them to target specific disease sites more accurately. This Special Issue, titled "Drug Delivery and Nanocarrier", invites researchers to share their latest findings, reviews, and perspectives on new nanocarrier designs and applications. We especially welcome studies that introduce new strategies for precise and controlled drug delivery, explore systems that integrate both diagnosis and treatment, or offer solutions to overcome biological barriers. Articles that investigate the safety, effectiveness, and potential clinical applications of these nanocarriers are also highly particularly welcome.
Dr. Jiawei Huo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- targeted drug delivery
- controlled release
- theranostics
- biocompatibility
- functionalized nanoparticles
- nanomedicine
- translational nanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
